Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ral GTPase-activating protein subunit alpha-1 (RALGAPA1) is a catalytic subunit of the heterodimeric RalGAP1 complex, which functions as a GTPase-activating protein (GAP) for the Ras-related GTPases RALA and RALB[1][2][7]. This activity promotes GTP hydrolysis, thus inactivating these GTPases and regulating signal transduction pathways, including those involved in cell growth, differentiation, and insulin-responsive signaling[1][7]. RALGAPA1 is essential for proper neurodevelopment and has been associated with rare neurodevelopmental disorders and has a reported tumor suppressor role as part of the RalGAP complex[2]. The gene has multiple aliases and encodes an enzyme required for GTPase activation, with mutations linked to developmental and epileptic encephalopathy among other phenotypes[1][3][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ral GTPase-activating protein subunit alpha-1 (RALGAPA1).